Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:31 PM
Ignite Modification Date:
2025-12-24 @ 12:31 PM
NCT ID:
NCT00712361
Eligibility Criteria:
INCLUSION CRITERIA:
Questions regarding INCLUSION must all be answered YES for subject study entry
1. Subject is 18 to 85 years of age? \[ \]Yes
2. Finger skin surface to be tested is free of injury or skin disease? \[ \]Yes
3. Subject is ambulatory? \[ \]Yes
4. Subject is willing and able to comply with the study requirements? \[ \]Yes
5. Subject is willing and able to provide written informed consent to participate in the study? \[ \]Yes
EXCLUSION CRITERIA:
Questions regarding EXCLUSION must all be answered NO for subject study entry
6. Subject is currently hospitalized ambulatory free? \[ \] No
7. Subject is currently abusing alcohol or illicit drugs, or has a history of alcohol abuse or illicit substance abuse within the preceding 2 years. For the purposes of the present study, alcohol abuse is arbitrarily defined as frequent consumption of alcoholic beverages with an average daily intake of more than 40gr of ethanol. Subject is currently on methadone maintenance treatment programs are NOT eligible for this study? \[ \] No
8. Subject has a medical condition that requires frequent or prolonged use of systemic corticosteroids (eg. Severe asthma, severe arthritis or autoimmune conditions; organ transplantation, adrenal insufficiency)?\[ \] No
9. The skin area to be tested clean of any damage (e.g. spotless, uncontaminated, dirt free, and hygienic)? \[ \] No
10. Subject has any other concurrent medical or social condition likely to preclude compliance with the schedule of evaluations in the protocol, or likely to confound the efficacy or safety observations of the study (e.g. concurrent active malignancy; frequent or uncontrolled seizure disorder; severe psychiatric disorder requiring psychotropic medication; active tuberculosis, pneumonia or other severe infection under current treatment; lives in a country other than the investigative site; or has other medical or social circumstances likely to interfere with the schedule or evaluations? \[ \] No
11. A history of treated malignancy that is not in complete remission of chemotherapy and/or radiotherapy and with additional surgical intervention during the preceding 3 years? \[ \] No
12. Subject is enrolled or plans to enroll from this study for any personal reason ? \[ \] No
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT00712361
Study Brief:
Protocol Section:
NCT00712361